FDA News

FDA bans most e-cigarette flavors

January 2, 2020
HHS Secretary Alex Azar announced that companies that do not stop manufacturing, distributing and selling unauthorized flavored cartridge-based…
In the Journals

Ramelteon and suvorexant effective for delirium prevention

January 2, 2020
Patients with delirium may benefit from taking ramelteon or Belsomra, according to results of a prospective observational study published in Journal
In the Journals

Researchers find neural target area for CBT in panic disorder

January 2, 2020
Panic disorder is associated with a biased panic-related semantic network that can be normalized using cognitive behavioral therapy, according to…
Feature

‘Focus on fun’: Reversing the trend of broken New Year’s resolutions

January 2, 2020
By the middle of February, some 80% of people will have broken their New Year’s resolutions, a clinical psychologist wrote in U.S. News and
In the Journals

Brain measurements at age 7 can predict future ADHD, MDD risk

December 31, 2019
Resting-state functional MRI metrics measured at age 7 years can be used to predict the developmental trajectory of ADHD and major depressive…
In the Journals

Cause-specific opioid mortality research reveals need for combination interventions

December 31, 2019
Individuals who use illicitly manufactured opioids or pharmaceutical opioids outside the bounds of a medical prescription experience significant yet…
In the Journals

Children with HIV show poorer neuropsychological performance

December 30, 2019
Children who were perinatally infected with HIV showed poorer scores on tests measuring cognitive ability, attention and motor function than their…

Top psychiatry stories of 2019

December 30, 2019
As 2019 draws to a close, Healio Psychiatry has compiled a list of the top stories of the year for psychiatrists and other mental health…
In the Journals

Prescribing antipsychotics at higher than 95% effective dose may not offer additional efficacy

December 30, 2019
Patients with chronic schizophrenia who have acute exacerbations may not experience increased benefit from receiving antipsychotic doses higher than…
In the Journals

Automotive plant closures linked to 85% increase in opioid overdose mortality

December 30, 2019
Opioid overdose mortality rates among working-age adults increased 85% in manufacturing counties in the 5 years after an automotive assembly plant…
In the Journals

Polygenic scores can help determine schizophrenia subgroups

December 27, 2019
Schizophrenia subgroups with distinct cognitive development trajectories can be determined using adult cognitive data, according to study findings…
In the Journals

Grandparents who care for grandchildren less likely to feel isolated, lonely

December 27, 2019
Grandparents who are active in the lives of their grandchildren may have a decreased risk for loneliness and social isolation, according to results…
In the Journals

Obesity during midlife linked to increased dementia risk in women

December 27, 2019
Women who were obese during midlife had a 21% greater risk for dementia compared with women who were not, according to a study published in…
In the Journals

Inflammatory biomarker may predict whether patients with CKD will benefit from antidepressants

December 27, 2019
Published findings determined that, for patients with chronic kidney disease and major depressive disorder, higher concentrations of the inflammatory…

Air pollution exposure may increase risk for depression, suicide

December 26, 2019
Higher levels of air pollution exposure may be associated with increased rates of depression and death by suicide among those exposed, according to…
In the Journals

Computer-automated decision support improves early screening rates for ASD

December 26, 2019
The use of computer automation in a clinical setting increased screening rates of children for autism spectrum disorder, according to findings of a…
FDA News

FDA approves Ubrelvy for acute treatment of migraine

December 23, 2019
The FDA has approved Ubrelvy, the first oral calcitonin gene-related peptide receptor antagonist intended for acute treatment of migraine in adults…
In the JournalsPerspective

Apps show teaching potential for math, early academic skills

December 23, 2019
Interactive apps show potential learning benefits for early academic skills like mathematics in children aged younger than 6 years, according to…
FDA News

FDA OKs Eisai’s insomnia drug, Dayvigo

December 23, 2019
The FDA approved Dayvigo 5 mg and 10 mg to treat adults with insomnia, according to a press release from the manufacturer. Dayvigo, (lemborexant…

Q&A: LGBT patients with Alzheimer's disease and their caregivers face specific challenges

December 23, 2019
Currently, 1.1 million LGBT individuals in the United States are aged 65 years or older, and recent estimates have predicted that this population…
Healio Jobs